Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 103
of 6Next
1:

Circulating alpha1-antitrypsin in the general population: determinants and association with lung function.

Senn O, Russi EW, Schindler C, Imboden M, von Eckardstein A, Brändli O, Zemp E, Ackermann-Liebrich U, Berger W, Rochat T, Luisetti M, Probst-Hensch NM; SAPALDIA Team.

Respir Res. 2008 Apr 25;9:35.

PMID: 18439253 [PubMed - indexed for MEDLINE]

2:

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

Demeo DL, Sandhaus RA, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard S, Burchard E, Stocks JM, Stoller JK, Strange C, Turino GM, Campbell EJ, Silverman EK.

Thorax. 2007 Sep;62(9):806-13. Epub 2007 Mar 27.

PMID: 17389752 [PubMed - indexed for MEDLINE]

3:

Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study.

Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, Neukirch F, Zureik M.

Respir Med. 2006 Dec;100(12):2112-20. Epub 2006 May 2.

PMID: 16650972 [PubMed - indexed for MEDLINE]

4:

SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations.

Zorzetto M, Russi E, Senn O, Imboden M, Ferrarotti I, Tinelli C, Campo I, Ottaviani S, Scabini R, von Eckardstein A, Berger W, Brändli O, Rochat T, Luisetti M, Probst-Hensch N; SAPALDIA Team.

Clin Chem. 2008 Aug;54(8):1331-8. Epub 2008 May 29.

PMID: 18515255 [PubMed - indexed for MEDLINE]

5:

Systemic inflammation and decline in lung function in a general population: a prospective study.

Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM.

Thorax. 2007 Jun;62(6):515-20. Epub 2007 Jan 24.

PMID: 17251312 [PubMed - indexed for MEDLINE]

6:

alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants.

Senn O, Russi EW, Imboden M, Probst-Hensch NM.

Eur Respir J. 2005 Nov;26(5):909-17.

PMID: 16264055 [PubMed - indexed for MEDLINE]

7:

Alpha-1 antitrypsin Null mutations and severity of emphysema.

Fregonese L, Stolk J, Frants RR, Veldhuisen B.

Respir Med. 2008 Jun;102(6):876-84. Epub 2008 Mar 18.

PMID: 18353624 [PubMed - indexed for MEDLINE]

8:

Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.

Undén AL, Elofsson S, Brismar K.

Clin Endocrinol (Oxf). 2005 Jul;63(1):94-102.

PMID: 15963068 [PubMed - indexed for MEDLINE]

9:

Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ).

Piitulainen E, Tornling G, Eriksson S.

Thorax. 1998 Nov;53(11):939-43.

PMID: 10193391 [PubMed - indexed for MEDLINE]

10:

C-reactive protein and coronary heart disease in western Turkey.

Onat A, Sansoy V, Yildirim B, Keleş I, Uysal O, Hergenç G.

Am J Cardiol. 2001 Sep 15;88(6):601-7.

PMID: 11564380 [PubMed - indexed for MEDLINE]

11:

Airway hyperresponsiveness in a large group of subjects with alpha1-antitrypsin deficiency: a cross-sectional controlled study.

Malerba M, Radaeli A, Ceriani L, Tantucci C, Grassi V.

J Intern Med. 2003 Mar;253(3):351-8.

PMID: 12603503 [PubMed - indexed for MEDLINE]

12:

Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD.

Rodriguez F, de la Roza C, Jardi R, Schaper M, Vidal R, Miravitlles M.

Chest. 2005 May;127(5):1537-43.

PMID: 15888825 [PubMed - indexed for MEDLINE]

13:

Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromsø Study 2001.

Melbye H, Halvorsen DS, Hartz I, Medbø A, Brox J, Eggen AE, Njølstad I.

Respir Med. 2007 Dec;101(12):2541-9. Epub 2007 Sep 6.

PMID: 17825547 [PubMed - indexed for MEDLINE]

14:

Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype.

Lussier-Cacan S, Bolduc A, Xhignesse M, Niyonsenga T, Sing CF.

Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):824-31.

PMID: 12006397 [PubMed - indexed for MEDLINE]

16:

Risk factors, pulmonary function, and mortality.

Menkes HA, Cohen BH, Beaty TH, Newill CA, Khoury MJ.

Prog Clin Biol Res. 1984;147:501-21.

PMID: 6610878 [PubMed - indexed for MEDLINE]

17:

Gender differences in the association between C-reactive protein, lung function impairment, and COPD.

Olafsdóttir IS, Gíslason T, Thjódleifsson B, Olafsson I, Gíslason D, Jõgi R, Janson C.

Int J Chron Obstruct Pulmon Dis. 2007;2(4):635-42.

PMID: 18268938 [PubMed - indexed for MEDLINE]

18:

Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.

Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1668-73.

PMID: 12377747 [PubMed - indexed for MEDLINE]

19:

Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study.

Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, Neukirch F.

Thorax. 2004 Oct;59(10):892-6.

PMID: 15454657 [PubMed - indexed for MEDLINE]

20:

Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study.

Raitakari M, Mansikkaniemi K, Marniemi J, Viikari JS, Raitakari OT.

J Intern Med. 2005 Nov;258(5):428-34.

PMID: 16238678 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 103
of 6Next